According to a recent safety announcement from the U.S. Food and Drug Administration (FDA), a treatment for restless legs syndrome and Parkinson's disease called Mirapex may lead to an increased risk of heart failure. The medication, sold under the generic name of pramipexole, faces additional scrutiny.
After review of pooled data from multiple studies, the FDA found that there was an increased risk of heart failure among patients who took the drug compared to placebo. These results did not reach statistical significance, suggesting that there may be a link but more review is necessary.
Symptoms of heart failure include shortness of breath, occurring either at rest or with exercise, as well as swelling in the feet, ankles, legs, or abdomen. An affected person may experience fatigue or weakness, chest pain, or persistent productive cough. Swelling can occur without heart failure as a side effect of the medication, so you should see your doctor to assess your situation if you suffer from this or any of the symptoms.
If you take Mirapex for the treatment of your medical condition, you should speak with your doctor about your potential risk before discontinuing the medication. As the FDA continues to investigate the potential association, more data and appropriate warnings will be released.